Objective: To evaluate the neuroprotective effect of ashwagandha extract against aluminum chloride-induced neurotoxicity in rats. Methods: Rats were divided into control, aluminumintoxicated rats treated daily with aluminum trichloride (AlCl 3 ) (100 mg/kg, orally) for 30 d and aluminum-intoxicated animals protected by receiving daily ashwagandha extract (200 mg/kg, orally) one hour before AlCl 3 administration for 30 d. Levels of lipid peroxidation, nitric oxide, reduced glutathione and tumor necrosis factor-α were measured in the cortex, hippocampus and striatum. In addition, the activities of Na + , K + , ATPase and acetylcholinesterase were determined in the three studied brain regions. Results: Aluminum increased the levels of lipid peroxidation and nitric oxide in the cortex, hippocampus and striatum and decreased the reduced glutathione level in the hippocampus and striatum. In rats protected with ashwagandha extract, non significant changes were observed in lipid peroxidation, nitric oxide and reduced glutathione. In addition, ashwagandha extracts prevented the increased activity of acetylcholinesterase and Na + , K + , ATPase induced by AlCl 3 in the cortex, hippocampus and striatum. The present findings also showed that the significant increase in tumor necrosis factor-α induced by AlCl 3 in the cortex and hippocampus was prevented by ashwagandha extract. Conclusions: The present results suggest that ashwagandha extract possesses antioxidant and anti-inflammatory effects against aluminum neurotoxicity. In addition, ashwagandha extract could prevent the decline in cholinergic activity by maintaining normal acetylcholinesterase activity. The later effect could recommend the use of ashwagandha as a memory enhancer.
Al is categorized as a neurotoxin and has hazardous effects on the development of the brain, prenatally or postnatally, in humans and experimental animals [6, 7] . It has been reported that the excessive Al intake for long time causes neuroinflammation and deficits in cognitive functions. Neuroinflammation alters dendritic spines density, which, in turn, influences cognitive function [8] .
Several in vitro and in vivo studies indicated that Al induces oxidative stress in the brain [9, 10] and the generation of reactive oxygen species (ROS) that exhaust the antioxidant mechanisms and induce lipid peroxidation, DNA damage, protein modification and other effects [11] . Gonzalez-Munoz et al. reported that aluminum trichloride (AlCl 3 ) causes a significant increase in malondialdehyde (MDA) and a significant decrease in glutathione (GSH) content [12] .
Other factors associated with Al neurotoxicity involve an increase in nitric oxide, ROS-induced damage and alterations in neurotransmission [13, 14] .
Aluminum can cross the blood brain barrier and accumulate in brain tissues [15, 16] with the highest concentrations in the hippocampus [17] .
A relationship between learning and memory deficits and Al exposure has been demonstrated by Exley [18] . It has been observed that AlCl 3 enhances pro-inflammatory cytokines production (TNF-α, IL-6) and nitric oxide in rat brain, probably by both astrocytes and microglia [19] and stimulates iNOS expression by immune-competent and phagocytes in the brain [20] .
Although the causes of Alzheimer's disease are not well understood, many studies propose Al as one of the potential contributing causes [21, 22] . This was supported by the reported functional deficits in spatial memory discrimination after chronic exposure of rats to Al in dietary supplements corresponding to the range of Al in urban American diets [23] . Moreover, experimental and human studies showed that Al caused an impairment in long-term memory [24] and hippocampal long-term potentiation [25] .
Ashwagandha [Withania somnifera (W. somnifera)] has many therapeutic uses in the ayurvedic system of traditional medicine.
Many toxicological studies demonstrated that ashwagandha is a safe and edible herb [26] . Several pharmacological effects of ashwagandha have been reported including antioxidant, antibacterial, adaptogen, liver tonic, aphrodisiac and anti-inflammatory effects [27] . In addition, the well-described pharmacological effects of ashwagandha include restoration of physiological and metabolic parameters, improvement of cognitive function in geriatric states, anti-arthritic, anti-aging, and recovery from neurodegenerative diseases [28] . Active constituents of W. somnifera include sitoindosides Ⅶ-Ⅹ and withaferin A which have antioxidative activities as evident from the activation of endogenous superoxide dismutase and catalase, the increase in vitamin C, and decrease in lipid peroxidation [29] .
Ashwagandha roots were used as tonic for the nervous system and in preventive health and were described as Medhya Rasayana (i.e. beneficial to the brain) in ayurveda literature [30] . The root extract of W. somnifera enhances cognitive function and augments the capacity of mental retention associated with diabetes, and the memory loss induced by amyloid beta (Aβ) and scopolamine [31, 32] . Recently, it has been reported that supplementation of withanolide enriched extract of W. somnifera root prevented the depletion of brain reduced glutathione and free radical scavenging enzymes and memory impairment induced by hypoxia by modulating brain corticosterone level through the nitric oxide-cyclooxygenase-prostaglandin pathways [33] .
It has been proposed that ashwagandha may improve cholinergic activity and this may underly its therapeutic potency against amnesia and neuroplasticity disorders constantly affected by age and stress [34] . The root extract of W. somnifera is also known to enhance the hippocampal cholinergic activity [31] .
Therefore the current study aimed to evaluate the neuroprotective efficacy of alcoholic ashwagandha extract against the neurotoxic effects of Al. This was carried out by studying the action of alcoholic ashwagandha extracts against the changes in levels of reduced glutathione, nitric oxide, lipid peroxidation and tumor necrosis factor-α induced by AlCl 3 in the cortex, hippocampus and striatum.
In addition, the effect of alcoholic ashwagandha extract in stead extracts on the changes in acetylcholinesterase and Na 
Material and methods

Experimental animals
Chemicals
AlCl 3 was obtained from Merck. Ashwagadha root powder was purchased from Imtinan Company, Egypt.
Preparation of alcoholic extract of ashwgandha
For preparation of ethanol extract 100 g of root powder was dissolved in 1 000 mL of ethanol and kept at 27 ℃ for 24 h under continuous stirring and filtered using Whatmann No. 1 filter paper.
The filtrate was then allowed to evaporate to get concentrated filtrate which was again reconstituted in small volumes of distilled water to obtain the used dose of ashwagandha (200 mg/kg).
Experimental design
The rats were divided randomly at the beginning of the experiment into three groups. The first group (n=7) is the control that received daily oral saline solution for 30 days. The second group (n=7) is the 
Nitric oxide
The spectrophotometric method described by Montgomery and Dymock was used to measure nitric oxide (NO) in the different brain areas [36] . Endogenous nitrite concentration was used as an indicator for nitric oxide levels. Griess reagent converted nitrite into an azo compound with a deep purple color whose absorbance was measured at 540 nm.
Reduced glutathione
Reduced GSH level was determined in the selected brain areas according to the method of Beutler et al [37] . The reduction of 'Ellman's reagent' [5, 5' dithiobis-(2-nitrobenzoic acid) or 5,5'-dithiobis-(2-nitrobenzoic acid)] with GSH produced a yellow compound whose absorbance was read spectrophotometrically at 412 nm. The obtained chromogen was directly proportional to GSH levels.
Acetylcholinesterase activity
Acetylcholinesterase (AchE) activity was determined by the modified method of Ellman et al [38] . The hydrolysis of acetylthiocholine iodide by acetycholinesterase yields thiocholine, which reacted with 5,5'-dithiobis-(2-nitrobenzoic acid), reducing it to thionitrobenzoic acid, whose yellow color was read at 412 nm. 
Statistical analysis
The present data were represented as mean±SEM. One-way analysis of variance was used to test the statistical significance between the different groups by Statistical Package for Social Sciences program. Duncan was applied as post hoc test to compare the significance between groups. Statistical significance was set at P-value <0.05.
Results
The present findings revealed that the daily treatment with AlCl 3 resulted in a significant increase in the cortical and hippocampal AchE activity by 137.974% and 167.360%, respectively, above the control values. However, striatal AchE activity showed nonsignificant changes. The parallel treatment of rats with ashwagandha and AlCl 3 prevented the increase in AchE activity induced by AlCl 3 .
Similarly, the activity of Na (Table 1) . Table 2 showed a significant increase in the level of cortical and hippocampal TNF-α in AlCl 3 -treated rats recording 17.36% and 48.95% more than the control values. The pretreatment with ashwagandha extract prevented the increased TNF-α induced by AlCl 3 .
In the present study one-way analysis of variance revealed a significantly increased value of MDA in the cortex (45.72%), hippocampus (384.44%) and striatum (461.56%) of AlCl 3 -intoxicated rats. AlCl 3 treatment also elevated significantly NO level in the cortex (165.22 %,), hippocampus (67.86%) and striatum (46.58%). In addition, GSH level declined significantly in the hippocampus (-27.60%) and striatum (-13.79%) and was elevated significantly in the cortex (12.48%) of rats treated with AlCl 3 when compared to control values ( Table 3 ).
The pretreatment of rats with ashwagandha extract restored the significant increase in MDA and NO level caused by AlCl 3 in the three studied brain regions to non significant changes as matched with the control value. Furthermore, ashwagandha extract restored the changes in GSH level induced by AlCl 3 to non significant changes (Table 3 ).
Discussion
Aluminum chloride has been established as a neurotoxic agent.
It accumulates gradually in the cortex and limbic structures of susceptible patients' brains initiating progressive hippocampal lesions that consist of dysfunctional microtubules, and reduced pyramidal cells with damaged neurites and synaptic loss. These lesions develop over time to clinically overt dementia [40] .
The present data revealed that Al induced oxidative stress in the cortex, hippocampus and striatum. This was evident from the significant increase in lipid peroxidation, which represents the main marker of oxidative stress, and nitric oxide levels in the studied brain regions. In addition, a significant decrease in GSH was recorded in the hippocampus and striatum. Our results agree with the findings of Shatei et al [41] who reported that Al decreased total antioxidant capacity and increased the levels of lipid peroxidation and nitric oxide in the cortex and hippocampus.
Aluminum is a metal characterized by relatively low redox activity; This could explain the elevation in lipid peroxidation in the cortex, hippocampus and striatum induced by Al in the present study. Values represent mean±SE with the number of animals (n); % D: % difference with respect to control values. Different letters indicate significantly different means P-value < 0.05; Same letters indicate non significant changes. The present significant increase in NO in the cortex, hippocampus and striatum could be due to the enhancement of nitric oxide synthase induced by Al [43, 44] . Nitric oxide can react with ROS such as superoxide forming peroxynitrite which is one of the potent damaging molecules for the nervous system [45] . This may represent one of the mechanisms that mediate Al-induced neurotoxicity.
Exaggerating this condition is the present reduction in GSH level in the hippocampus and striatum of Al-intoxicated rats. GSH is a nonenzymatic antioxidant that has a potential role in the brain tissue against free radicals production and neurodegeneration [46] . The depletion of GSH represents an early hallmark in the progressive cell death that results from apoptotic stimuli in several cell types [47, 48] .
The depletion in GSH after Al may be due to the reduced synthesis resulting from the decrease in the activity of glutathione synthetase enzyme which needs ATP as a co-substrate [49] . Therefore, the present decrease in GSH level in the hippocampus and striatum may be due to its exhaustion to get rid of the evolved ROS and failure to replenish its content after Al exposure.
One of the contributing factors in Al-induced neurotoxicity is the high sensitivity of the brain tissue to oxidative stress. This is due to the high content of unsaturated fatty acid in the brain, the high metabolic rate and the relatively low brain antioxidant capacity [50, 51] .
The present findings revealed a significant increase in TNF-α level in the cortex and hippocampus of AlCl 3 -intoxicated rats. Passos et al.
reported that inflammation might contribute to the neurodegenerative effects of AlCl 3 , through the increased expression of cytokines such as TNF-α in activated microglia around amyloid plaque [52] . This confirms the presence of a direct link between neurotoxicity induced
by Aβ and cytokines [53] . Aluminum is a well documented neurotoxin that induces neuroinflammation by several mechanisms. Aluminum triggers oxidative stress, deposition of Aβ, and plaque formation in transgenic mice brain with increased expression of amyloid beta precursor protein. Both Aβ and aluminum act to augment ROS production that may lead to genotoxicity and DNA damage [9] .
The observed oxidative stress and neuroinflammation induced by
Al in the present study were accompanied by an increase in AchE activity in the cortex, hippocampus and striatum.
Kaizer et al. also observed that Al induced an increase in AchE and lipid peroxidation in several mice brain regions [14] . Aluminum has been reported to cause changes in cholinergic function in the CNS [54] . It has been suggested that aluminum could act as a cholinotoxin by interacting with the cholinergic system [55] . It is hypothesized that the decrease in the integrity of cholinergic neurotransmission is predominantly related to the decline in memory and cognitive functions during aging [56] . Interference in cholinergic signaling has been found to modulate the expression of activityregulated cytoskeletal-associated protein [57] , regulated by a neuronal immediate early gene critical for synaptic plasticity [34] . In addition, the exposure to Al even at low doses can result in a dramatic accumulation of Al in the brain leading to a severe impairment in learning and memory abilities, and long-term potentiation in the hippocampus [25] .
Therefore, the present increase in AchE in the studied brain regions could result in a decrease in cholinergic activity. This mechanism may underlie the reported deficits in memory and cognition induced by aluminum.
The increase in Na functions especially in specialized cells [58] . The increase in the brain excitability could arise from the stimulant effect of Al on glutamate neurotransmitter which is the main excitatory neurotransmitter in the brain [59] . Therefore, the present increase in Na Interestingly, TNF-α, which increases after aluminum exposure, is a key cytokine that triggers glutamate release from microglia, by up-regulating glutaminase and gap junction hemichannels [60, 61] .
The interaction between TNF-α and glutamate is known as immunoexcitotoxicity based on adverse interactions between TNF-α as an inflammatory cytokine and glutamate as an excitotoxin [62] .
Supporting this explanation is the present observed oxidative stress and the increase in NO which may be occurred following increased glutamate release, increased calcium influx and excitotoxicity [63] .
It is clear from the present study the AlCl 3 induced a state of neurotoxicity mediated by oxidative stress, and neuroinflammation in the cortex, hippocampus and striatum of rats. This was associated with reduced cholinergic activity mediated by an enhancement of AchE activity. This effect was more prominent in the hippocampus which is a part of the limbic system needed for formation of various types of memory and learning in mice and other mammalians.
In human, any damage to the hippocampus leads to disorders in learning capability, memory, remembering places and other undesired mental effects [64] .
Pro-inflammatory cytokines have been reported to impair long-term potentiation, and inhibit neurotrophins which are critical for neuronal survival and function, synaptic plasticity and memory [65] . Moreover, altered density of hippocampal dendritic spines was evident after the exaggeration of the pro-inflammatory cytokine response [66] .
Alterations in dendritic spines control synaptic plasticity, which, in turn affect learning and memory [67] . Therefore, the present effects induced by AlCl 3 support the hypothesis that Al may be a suspected factor in the etiology of Alzheimer disease.
The present results showed that the daily pretreatment of ashwagandha extract prevented the oxidative stress resulting from AlCl 3 in the cortex, hippocampus and striatum. This was indicated from the ability of ashwagandha root extract to prevent the elevation in lipid peroxidation and NO induced by AlCl 3 and to restore the significant reduction in GSH to control like value.
It has been reported that W. somnifera contains a high content of phenolic compounds with potent antioxidant activity [68] . Moreover, its extract elevates antioxidant capacity and could be used as a protective agent against cellular damage induced by free radicals [69] .
The antioxidant effects of ashwagandha root extract could also be due to the high concentrations of withanolides, flavonoids and other components which are potent antioxidants [70] . It has been shown that W. somnifera root can increase the synthesis of glutathione in the hippocampus exposed to hypobaric hypoxia [33] . Therefore, the ashwagandha extract could have a potential antioxidant effect in Alintoxicated rats. This effect could be explained by the abundance of phenolic compounds in its structure on one hand and the increased GSH synthesis on the other hand. Moreover, it has been reported that GSH forms S-nitrosoglutathione with NO thus serving as an endogenous reservoir for NO [71] . Thus, the increased GSH synthesis induced by ashwagandha extract can modulate the elevated level of NO induced by Al. This in turn could prevent the toxic effects of NO and prevent the formation of peroxynitrite.
Recently, Shah et al. postulated that the neuroprotective effect of ashwagandha extract may be caused by the reduction of oxidative stress and glutamate insults [29] . In the present study, ashwagandha extract restored the elevated level of TNF-α induced by AlCl 3 to nonsignificant changes as compared to control value. This in turn will reduce glutamate release and thus the immunoexcitotoxicity induced by AlCl 3 . Thus ashwagandha-reduced glutamate release could be explained by the decrease in the level of TNF-α and its effect on glutamate release. As a result of this effect, the cascade of events induced by the increased glutamate release including the increased influx of calcium ions and increased free radical and NO production [63] will be prevented. This could explain the reduced level of NO and MDA induced by ashwagandha extract. Moreover, the reduced glutamate release will minimize the membrane depolarization and excitotoxicity and this could explain the present recovery of Na + , K + , ATPase activity induced by ashwagandha extract. Supporting this explanation is the study of Kataria et al [72] who found that low doses of withanone and ashwaganda extract protect against glutamate-induced excitotoxicity.
Several studies reported that ashwagandha increases cholinergic activity. Gautam et al. provided several biochemical and molecular evidence that ashwagandha leaf extract possesses cholinergic properties in brain disorders associated with cholinergic dysfunction [32] . The authors found that the root extract of W.
somnifera (ashwagandha) could augment cholinergic activity in the hippocampus [32] . This augmentation may underlie the protective effects of ashwagandha extract against scopolamine-induced loss of memory function [73] . The root extract of the ashwagandha and withanolide A, one of its active components, have been shown to improve the cognitive deficits and spatial memory impairements in temporal lobe epilepsy and experimental models of stroke [74, 75] .
AchE is the central metabolizing enzyme of acetylcholine. Therefore, the present potential effect of ashwagandha extract against AlCl 3 -induced increase in AchE activity could play a potential role in restoring the cholinergic activity to its control values. Accordingly, ashwagandha extract could alleviate the reported cholinotoxicity of AlCl 3 [55] .
In the light of the present data, it could be concluded that the alcoholic extract of aswagandha has a protective effect against aluminum neurotoxicity. This effect was mediated by preventing the oxidative stress, neuroinflammation, and excitotoxicity induced by aluminum. In the light of the obtained results, ashwagandha extract could be offered as an adjuvant therapy against Alzheimer's disease.
